Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 May 2025 | Story Martinette Brits | Photo Kaleidoscope Studios
Prof Hendrik Swart
Prof Hendrik Swart from the UFS Department of Physics was recently recognised by the Golden Key Honour Society Southern Africa as one of South Africa’s 300 most influential leaders.

Prof Hendrik Swart from the University of the Free State (UFS) Department of Physics was recently honoured at the Golden Key Honour Society Southern Africa’s Black Tie Gala Event, held on 23 May 2025. The event celebrated 300 of South Africa’s most influential leaders across academia, industry, government, and the financial sector.

Prof Swart, who is an NRF B1-rated researcher and currently also holds the SARChI Research Chair in Solid-state Luminescent and Advanced Materials (2023-2027), described the recognition as both meaningful and affirming at this stage of his academic journey.

“Being recognised by such a prestigious organisation is a meaningful acknowledgment of my academic efforts and personal dedication,” he says. “It was a moment of validation and inspiration, reminding me that hard work truly pays off.”

While the exact selection criteria were not publicly detailed, the emphasis was placed on academic excellence, scholarship, and leadership.

This is not Prof Swart’s first recognition from the Golden Key Honour Society. In 2012, the UFS student chapter awarded him honorary membership for his contributions as a mentor and supervisor – an early nod to his lasting impact on student success.

“The student chapter here on campus gave me some recognition by awarding me honorary membership,” he recalled. “It meant a lot to me as a mentor.”

The gala itself offered more than accolades – it created a space for meaningful exchange. Prof Swart reflected warmly on reconnecting with one of his former students from the early 2000s, calling it a highlight of the evening.

Looking ahead, Prof Swart welcomed the society’s plans to continue this initiative across the country.

“This was the first time they had an event like this, but more are expected to follow. I see it as a good initiative to mingle with other sectors in South Africa.”

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept